Saccomano Nicholas Ainsider trades
In SEC Form 4 filings, Saccomano Nicholas A is listed as President and CEO of OnKure Therapeutics, Inc. (OKUR). In the last 90 days, Saccomano Nicholas A sold $258.76 of OnKure Therapeutics, Inc. (OKUR) on the open market and bought none.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| OKUROnKure Therapeutics, Inc. | President and CEO | 1 | Sep 23 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-23
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.